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Background: Nicotine is a major toxic component of tobacco smoke and has been recognized as a risk factor to induce oxidative tissue 
damage, which is a precursor to cardiovascular diseases, lung-related diseases, and cancers. Peaches (Prunus persica) have been used 
for the treatment of degenerative disorders, such as hypermenorrhea, dysmenorrhea, and infertility in Asian countries. In this study, 
we investigated the effects of white-fleshed peach on the excretion of nicotine metabolites and 1-hydroxypyrene in smokers and chronic 
nicotine-induced tissue damages in mice.
Methods: The concentrations of cotinine and 1-hydroxypyrene were measured in urine of smokers before or after intake of white-fleshed 
peaches. In addition, ICR mice were injected with nicotine (5 mg/kg body weight) and then orally administered with white-fleshed peach 
extracts (WFPE) (250 or 500 mg/kg body weight) for 36 days. The oxidative stress parameters and the activities of antioxidant enzymes 
were measured in liver and kidney tissues. Also, histological changes and nitrotyrosine expression were assessed. 
Results: Intake of white-fleshed peaches increased the urinary concentration of nicotine metabolites and 1-hydroxypyrene in 91.67%  
and 83.33% of smokers, respectively. WFPE decreased the malondialdehyde levels and recovered the activities of antioxidant enzymes 
in nicotine-injected mice. In addition, WFPE inhibited nitrotyrosine expression and inflammatory responses in the liver, kidney, and lung 
tissues of nicotine-treated mice. 
Conclusions: White-fleshed peaches may increase the metabolism of toxic components in tobacco smoke in smokers and protect normal 
tissues against nicotine toxicity in mice. Therefore, supplementation of white-fleshed peaches might be beneficial to smokers.
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INTRODUCTION
Smoking is a critical public health problem that negatively 
affects quality of life. It has been strongly implicated as a risk 
factor for chronic obstructive pulmonary disease, lung cancer, 
and cardiovascular disorders.1 Furthermore, cigarette smoking 
has been considered as an important risk factor that leads to 
cancers of the stomach, liver, and pancreas, as well as renal cell 
carcinoma and transitional cell carcinomas of the urinary bladder 
and renal pelvis.2-4
Nicotine, a major alkaloid constituent of tobacco, is metabo-
lized to several metabolites and excreted into the urine. In saliva 
or urine samples, nicotine metabolites have been used to 
evaluate smoking status quantitatively. Nicotine and its major 
metabolite, cotinine, have carcinogenic effects because they bind 
to nicotinic acetylcholine receptors on non-neuronal cells.5,6 
Chronic nicotine exposure induces lipolysis and hepatoto-
xicity.7,8 It results in oxidative stress by inducing the generation of 
reactive oxygen species (ROS). Previous experiments have shown 
that administration of nicotine to rats resulted in increased levels 
of lipid peroxidation products.9 Chronic nicotine exposure also 
causes oxidative damages by decreasing the activity of endo-
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genous antioxidants, such as catalase (CAT) and superoxide 
dismutase (SOD).10 These evidences support the role of oxidative 
stress in the toxicity of nicotine. 
Several natural products and compounds, including flavonoids, 
have been used to protect against toxicity induced by long-term 
drug treatments of chronic diseases or cancers and carcinogenic 
xenobiotics existing in many junk foods, alcohol, and other 
environmental toxicants. Peaches (Prunus persica (L.) Batsch), 
including various species, are consumed and used as a dietary 
supplement worldwide. P. persica seeds (Persicae Semen; Tounin) 
are well-known in many Asian countries as a traditional medi-
cine. The chemical constituents of peach seeds, including struc-
turally simple glycosides, have significant anti-tumor activity.11 
The ethanol extract of P. persica also inhibits mast cell-mediated 
allergic inflammatory reactions in in vivo models.12 Previous 
studies reported that the extract of P. persica flesh protects 
against hepatotoxicity and nephrotoxicity induced by cisplatin, 
which is prescribed to treat solid tumors in mice.13,14 Low-acid 
white-fleshed peaches are most popular in Asian countries, such 
as Korea, China, and Japan, while Europeans and North 
Americans consume mainly yellow-fleshed peaches with high 
acidity and low sweetness. Therefore, we investigated whether 
intake of white-fleshed peaches affects the excretion of nicotine 
metabolites and 1-hydroxypyrene in the urine of smokers. 
Furthermore, we evaluated the protective effect of white-fleshed 
peach extracts (WFPE) on chronic nicotine-induced tissue toxicity 
by determining the biochemical parameters and histological 
examination in an animal model.
MATERIALS AND METHODS
1. Materials
(−)-Cotinine, 1-hydroxypyrene, nicotine hydrogen bitartrate, 
sodium acetate, potassium cyanide, chloramine, barbituric acid, 
and -glucuronidase/arylsulfatase were obtained from Sigma-Al-
drich (St. Louis, MO, USA). Methanol was purchased from Merck 
(Darmstadt, Germany). All reagents used in this study were of 
analytical grade. The white-fleshed fruits of Prunus persica (L.) 
Batsch (Family Rosaceae; peaches) were purchased at the Kyeon-
ggi Dong-Boo Fruit Agriculture Co. (Incheon, Korea), where a 
voucher specimen (PE20060801) has been deposited. 
2. Subjects
Twelve healthy adult Korean male smokers volunteered for the 
study to investigate the effects of white-fleshed peaches on the 
excretion of nicotine metabolites and 1-hydroxypyrene into the 
urine. Subjects signed the informed consent form; smoking 
status and number of cigarettes per day were assessed using a 
self-administrated questionnaire. Urine, saliva, and blood were 
collected before intake of white-fleshed peaches and four days 
after intake. Participants intaked three fruits a day for four days. 
Before the study began, informed written consent was collected 
from all participants according to the ethical guidance of the 
Institutional Review Board of Yonsei University College of 
Dentistry, Seoul, Korea.
3. Determination of nicotine metabolite 
An aliquot of urine sample (500 L) was mixed with 500 L 
ethanol, 200 L 4 M acetate buffer (pH 4.7), 100 L 1.5 M 
potassium cyanide, 100 L 0.44 M chloramine, and 500 L 78 mM 
barbituric acid. As a reference, 500 L urine sample were diluted 
with 1.4 mL deionized water. After 100 minutes at room 
temperature, absorbance was measured at 508 nm using a 
microplate reader (BIO-RAD Laboratories, Hercules, CA, USA). 
Since values obtained by the colorimetric method were sums of 
nicotine metabolites, we expressed them as cotinine equivalent 
concentrations using cotinine as a standard.
4. Determination of 1-hydroxypyrene 
Ten milliliters of urine were transferred to a flask. The pH of 
the solution was adjusted to 5.0 with 1 M HCl, and then 2.5 mL 0.5 
M acetate buffer (pH 5.0) were added. After addition of 20 L 
-glucuronidase/arylsulfatase (131,400 units/mL and 7,500 
units/mL at pH 5.0 and 37oC, respectively), the flask was placed in 
a shaker for 16 hours at 37oC to completely hydrolyze the 
polycyclic aromatic hydrocarbons (PAHs) hydroxide conjugates. 
After hydrolysis, samples were centrifuged at 850 ×g for 10 
minutes, and the supernatant was used for solid phase 
extraction. The Discovery C18 solid phase extraction cartridge 
(Supelco, Bellefonte, PA, USA) was pretreated with 5 mL of 
methanol and 5 mL deionized water. The hydrolyzed urine 
sample was loaded onto the cartridge at a flow rate of ＜1 
mL/min. The column was washed with 10 mL of water and 10 mL 
30% methanol to remove the matrix interferences. After the 
cartridges were dried completely, the trapped metabolites were 
eluted with 4 mL methanol. The eluate was concentrated almost 
to dryness under a gentle stream of nitrogen and dissolved in 1 
mL methanol. The solution was filtered through a 0.2-m filter 
and stored at −20oC before the high-performance liquid 
chromatography (HPLC) analysis. The stock standard solution 
(0.2 g/L) of 1-hydroxypyrene was prepared by dissolving 5.0 mg of 
solid standard in methanol in a 25-mL volumetric flask. Dilutions 
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in methanol were prepared to concentrations of 100 and 1.0 g/L 
and stored in the dark at 4oC.
The Shimadzu HPLC system consists of a model SCL-10AVP 
system controller, a model LC-10ADVP micro-plunger pump, a 
model DGU-14A degasser, a model SIL-10ADVP auto sampler, a 
model CTO-10ASVP column oven, and a model RF-10AXL 
fluorescence detector (Shimadzu, Kyoto, Japan). The system was 
monitored by Shimadzu Class VP software (ver. 6.12 SP3). The 
reverse-phase chromatography was performed on a Discovery 
C18 column (150.0 × 4.6 mm, 5 m particle size; Supelco). The 
mobile phase was methanol-water (60:40, v/v) at a flow-rate of 1 
mL/min. The injection volume was 10 L, and the total run time 
was 30 minutes. The retention time of 1-hydroxypyrene in these 
conditions was 17 minutes. The eluted peaks were monitored at 
excitation and emission wavelengths of 242 and 388 nm, 
respectively.
5. Measurement of creatinine and cotinine 
Urinary creatinine levels were evaluated spectrophoto-
metrically, using commercially available kits (Asan Pharmaceu-
tical, Seoul, Korea). Salivary cotinine levels were determined 
using a High Sensitivity Salivary Cotinine Quantitative Enzyme 
Immunoassay kit (Salimetrics, State College, PA, USA).
6. Preparation of white-fleshed peach extracts 
The pericarps and seeds were removed from peaches, and the 
collected white-flesh was extracted thrice in five volumes (w/v) of 
80% ethanol for 48 hours at room temperature. The extracts were 
filtered, concentrated by vacuum evaporating the solvent in a 
rotary evaporator, and freeze-dried. The dried extracts of 
white-fleshed peaches were stored at −20oC. 
7. Animals and experimental design 
Male ICR mice (25-30 g body weight, 5-week-old) were 
purchased from the Central Laboratory Animal Inc. (Seoul, 
Korea). They were provided free access to a commercial rodent 
chow (Daejong Inc., Seoul, Korea) and tap water ad libitum. All 
animals were housed under specific pathogen-free conditions 
with a 12 hours light-dark cycle and a relative humidity of 55% ± 
5% at 25oC ± 2oC. All experimental procedures were performed in 
accordance with the guidelines and regulation for the use and 
care of animals established by the Animal Ethics Committee of 
Yonsei University College of Dentistry (IACUC Approval Number: 
2012-0092). Mice randomly divided into five groups, each with six 
animals of similar average body weights. Group I as control mice 
were intraperitoneally injected with saline. Group II was 
administrated WFPE daily at a dose of 500 mg/kg body weight 
orally alone. Group III was injected with nicotine hydrogen 
bitartrate intraperitoneally at a dose of 5 mg/kg body weight daily 
for 5 weeks. Group IV or V received daily intraperitoneal 
injections of nicotine 5 mg/kg and oral administration of WFPE 
250 mg/kg or 500 mg/kg for 5 weeks. The individual body weights 
of all animals were measured once every other day. At the end of 
the experiment, all mice were anesthetized, and blood samples 
were taken from the intracardiac puncture. The blood samples 
were allowed to clot at room temperature for 2 hours, and then 
centrifuged at 2,000 ×g for 20 minutes to obtain the serum. The 
serum samples were stored at −80oC to assess hepatic and renal 
function. The liver, kidney, and lung tissues were removed for the 
biochemical assay and histopathological examination.
8. Determination of serum biochemical parameters
In order to evaluate hepatic function, serum alanine amino-
transferase (ALT) and aspartate aminotransferase (AST) levels 
were measured. Serum blood urea nitrogen (BUN) and creatinine 
levels were assessed as indicators of renal function. All bio-
chemical assays were performed using commercially available 
kits from YeongDong Pharmaceutical Co. (Seoul, Korea) according 
to the manufacturer’s instructions. The absorbance of all bio-
chemical assays were measured in a POLARstar Omega micro-
plate reader (BMG LABTECH, Offenburg, Germany). 
9. Preparation of tissue homogenates
The liver and kidney tissues isolated from all mice were 
immediately washed with an ice-cold PBS (pH 7.4) to remove the 
blood. The tissues were cut into small pieces with scissors on ice. 
The sliced tissues (100 mg) were subsequently homogenized in 
1.0 mL of cold 1.15% KCl buffer (pH 7.4) including 100 mM 
phenylmethylsulfonyl fluoride. The homogenates were centri-
fuged at 800 ×g  for 20 minutes at 4oC. Aliquots of the super-
natant were collected and stored at −80oC to measure the levels 
of lipid peroxidation and glutathione (GSH) and the activity of 
antioxidant enzymes. Total protein concentrations in the 
supernatants were determined using a bicinchoninic acid protein 
assay kit (Pierce Biotechnology Inc., Rockford, IL, USA). 
10. Determination of lipid peroxidation and glutathione 
levels
In the homogenates of the liver and kidney tissues, the level of 
malondialdehyde (MDA), an indicator of lipid peroxidation, was 
determined by monitoring thiobarbituric acid (TBA) reactive 
substance formation as described previously.15 Lipid peroxi-
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dation was expressed in terms of MDA equivalents using an 
extinction coefficient of 1.56 × 105 M−1cm−1 and the final MDA 
level is represented as mol per g tissue. MDA reacts with TBA in 
the homogenate sample to form a colored complex that has an 
absorbance at 532 nm in a spectrophotometer. 1,1,3,3-tetrame-
thoxypropane was utilized as a standard curve. The total GSH 
content of the tissue homogenates was detected at 412 nm 
colorimetrically using a reaction with Ellman’s reagent [5,5'-dithi-
obis(2-nitrobenzoic acid) or DTNB].16 GSH level is expressed as 
M per g tissue. 
11. Measurement of antioxidant enzyme activities 
SOD activity was measured using the SOD determination kit 
(Sigma-Aldrich) in accordance with the manufacturer’s protocols. 
SOD assay kit-WST allows SOD assaying by utilizing Dojindo’s 
highly water-soluble tetrazolium salt, WST-1 [2-(4-lodophe-
nyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyle)-2H-tetrazolium, 
monosodium salt] for detection of the superoxide anions 
generated by xanthine oxidase and xanthine. One unit (U) of SOD 
represents the amount of enzyme needed to inhibit 50% of the 
dismutation of superoxide radicals. 
CAT activity was measured by the Catalase Assay Kit (Cayman 
Chemical, Ann Arbor, MI, USA), which utilizes the peroxidase 
function of CAT for determination of enzyme activity. It is based 
on an enzyme reaction with methanol in the optimal concen-
tration of hydrogen peroxide. One unit (U) of CAT activity is 
defined as the amount of enzyme that results in the formation of 
1 nM of formaldehyde per minutes at 25oC. 
The glutathione peroxidase (GPx) activity was determined 
using a glutathione peroxide assay kit (Cayman Chemical, Ann 
Arbor, MI, USA) according to the manufacturer’s instructions. The 
assay indirectly measures GPx activity using a coupled reaction 
with GSH reductase by monitoring the oxidation of reduced 
NADPH at 340 nm. One unit (U) of GPx activity is defined as the 
amount of enzyme that will oxidize 1.0 nM of NADPH per minutes 
at 25oC. GPx activity was calculated using the actual extinction 
coefficient for NADPH at 340 nm (6.22 × 106 M−1ㆍcm−1). 
Enzyme activities are expressed as U per mg tissue protein.
12. Histology and immunohistochemistry
The liver, kidney, and lung tissues were fixed in 10% buffered 
formalin solution and embedded in paraffin. Tissue specimens 
were cut into sections 5-m thick and stained with hematoxylin 
and eosin. For immunohistochemical analysis, the sections were 
incubated with 3% hydrogen peroxide in absolute methanol for 
10 minutes at room temperature, followed by 30 minutes of 
incubation with 3% bovine serum albumin in PBS. All tissue 
sections were incubated with primary antibodies against 
nitrotyrosine (Millipore, Billerica, MA, USA) for 1 hour at room 
temperature in a humidified chamber. After washing thrice with 
PBS containing 0.05% Tween-20, the specimens were incubated 
with horseradish peroxidase-conjugated antibody (Zymed Lab., 
San Francisco, CA, USA), and then stained with 
3,3-diaminobenzidine as chromogen (Life Science Division, 
Mukileto, WA, USA). The sections were counterstained with 
Mayer’s hematoxylin and evaluated with the Zeiss Axio Imager 
microscope. 
13. Statistical analysis
Data is expressed as the mean ± SE (SEM). Groups of data were 
compared with one-way ANOVA followed by Tukey’s multiple 
comparison test. P-values of less than 0.05 were considered 
statistically significant. Statistical analysis was performed with 
IBM SPSS software ver. 21 (IBM Co., Endicott, NY, USA).
RESULTS
1. Effect of white-fleshed peach on the excretion of 
nicotine metabolites and 1-hydroxypyrene in the 
urine of smokers
Nicotine is metabolized into several metabolites and excreted 
in the urine. Cotinine, the major metabolite of nicotine, is a 
sensitive and specific biochemical marker of exposure to cigarette 
smoke. The main metabolite of PAHs, 1-hydroxypyrene, is pre-
ferentially used as a biomarker of carcinogen exposure such as 
cigarette smoke.17 As shown in Figure 1A, intake of white-fleshed 
peaches increased the concentration of nicotine metabolites 
excreted in the urine of 11 out of 12 smoker volunteers (91.67%), 
compared to levels before intake (control). Salivary cotinine 
concentration was used for correction of urinary nicotine 
metabolite concentration. Intake of white-fleshed peaches raised 
the urinary level of 1-hydroxypyrene excreted from 10 out of 12 
smoker volunteers (83.33%) (Fig. 1B). Urinary 1-hydroxypyrene 
concentration was corrected by urinary creatinine concentration. 
Intake of white-fleshed peaches did not have a remarkable effect 
on the average salivary and plasma cotinine concentrations, 
although salivary and plasma cotinine concentrations showed 
individual differences.
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Figure 1. Effect of white-fleshed 
peach on the excretion of nicotine 
metabolites and 1-hydroxypyrene in 
urine of smokers. Urine and saliva of
subjects were collected before intake 
of white-fleshed peach and 4 days af-
ter intake. (A) Nicotine metabolite 
concentration in urine and cotinine 
concentration in saliva were meas-
ured by the colorimetric method and
the enzyme immunoassay, respectively.
(B) The 1-hydroxypyrene and crea-
tinine concentrations in urine were 
measured by high-performance liquid
chromatography analysis and colori-
metric method, respectively. Urinary
nicotine metabolite concentration and
1-hydroxypyrene concentration were 
corrected by salivary cotinine concen-
tration and urinary creatinine con-
centration, respectively. Data are ex-
pressed as mean ± SEM. *P ＜ 0.05
versus control (before intake).
2. Effect of white-fleshed peach extracts on nephro-
toxicity and hepatotoxicity in nicotine-injected mice
We conducted an animal experiment to study the effect of 
white-fleshed peaches on tissue toxicity by chronic nicotine 
treatment. First, to evaluate the effect of nicotine toxicity and 
WFPE administration on body weight, we measured the weights 
of all mice every other day during the experimental period. Body 
weights of the control mice gradually increased, while the 
nicotine group gained weight up to day 20 and lost weight 
thereafter until the end of the experiment (data not shown). 
However, administration of WFPE restored the decreased body 
weight in nicotine-injected mice. 
The protective effect of WFPE against chronic nicotine-in-
duced renal and hepatic toxicity was assessed by measuring 
biochemical parameters in sera of the mice. We analyzed BUN and 
creatinine levels for kidney function, and AST and ALT levels for 
liver function. The mice treated with WFPE alone did not show 
any kidney or liver dysfunction, but nicotine raised the levels of 
all biochemical parameters in the mouse sera (Fig. 2). In contrast, 
WFPE treatment dose-dependently lowered serum levels of BUN, 
creatinine, AST, and ALT that were elevated by nicotine. In 
particular, the serum BUN and ALT levels were recovered almost 
to control levels at a WFPE dosage of 500 mg/kg. 
3. Effect of white-fleshed peach extracts on oxidative 
damages in liver and kidney tissues of nicotine-in-
jected mice
To investigate the effect of WFPE on chronic-induced oxidative 
tissue damages, MDA, and GSH contents, as well as antioxidant 
enzyme activities, were measured in the liver and kidney tissue 
homogenates from all the mice. The level of MDA, which is a 
major degradation product of lipid peroxidation, increased after 
chronic nicotine treatment when compared to the control group 
(Fig. 3A). However, administration of higher-dose WFPE to 
nicotine-injected mice significantly reduced tissue MDA levels 
and showed a more pronounced reduction effect in the liver than 
the kidney.
The antioxidative status was assessed by measuring GSH 
content and the activities of antioxidant enzymes in the liver and 
kidney tissues. In the nicotine-injected mice, the level of GSH and 
the activities of SOD, GPx, and CAT were significantly lower than 
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Figure 2. Effect of white-fleshed peach extracts (WFPE) on chronic nicotine-induced nephrotoxicity and hepatotoxicity in mice. Nicotine (5 
mg/kg body weight [BW]) and/or WFPE (250 mg/kg BW or 500 mg/kg BW) were administered to mice (n = 6) once daily for 5 weeks. The 
control mice (n = 6) received saline alone. (A) The serum blood urea nitrogen (BUN) and creatinine levels were measured using commercially 
available kits for analysis of nephrotoxicity. (B) The serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) 
were analyzed as evidence of hepatotoxicity. Data are expressed as mean ± SEM (n = 6 per group). #P ＜ 0.05 versus control group; *P
＜ 0.05 versus nicotine group.
the control group (Fig 3B and 3C). The WFPE-treated group 
showed recovery of GSH levels and antioxidant enzyme activities. 
4. Effect of white-fleshed peach extracts on nicotine- 
induced histological changes and nitrotyrosine ex-
pression in liver, kidney, and lung tissues
Histological analysis revealed that chronic nicotine admi-
nistration resulted in significant tissue damage and changes 
when compared to the tissues of control mice (Fig. 4A). Mi-
croscopic evaluation of the liver in the control group showed 
hepatocytes arranged in rows that radiate out from the central 
vein. In the liver tissues of nicotine-injected mice, however, 
severe necrosis of hepatocytes and infiltration of inflammatory 
cells were present; additionally, sinusoidal congestion was 
observed. Treatment with WFPE at 250 mg/kg reduced necrosis 
and showed moderate infiltration of inflammatory cells. In the 
liver sections of the higher dose WFPE-treated mice, infla-
mmatory cell infiltrates were rare, and necrosis was not observed. 
The normal kidney samples showed prominent regular struc-
tures of glomeruli and renal tubules. In the nicotine alone group, 
kidney sections showed vacuolation of tubular cells and wide 
dilatations in the glomeruli. Treatment with WFPE dose-de-
pendently inhibited the morphologic changes induced by 
nicotine. 
In the lung tissue, the control group showed normal alveoli 
with thin alveolar septa. However, nicotine treatment 
induced edema, moderate hemorrhage, and a remarkable 
thickening of the alveolar septa with hyperplasia of the 
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Figure 3. Effect of white-fleshed peach extracts (WFPE) on chronic nicotine-induced oxidative stress in mouse tissues. After mice were adminis-
trated nicotine (5 mg/kg body weight [BW]) and/or WFPE (250 mg/kg BW or 500 mg/kg BW) for 5 weeks, liver and kidney tissues were collected
and homogenized. (A) The level of malondialdehyde (MDA), as an indicator of lipid peroxidation, was measured in tissue homogenates. (B) 
Glutathione (GSH) content was evaluated by the reaction with Ellman’s reagent. (C) Among the enzymatic antioxidants, superoxide dismutase 
(SOD), glutathione peroxidase (GPx), and catalase (CAT) were analyzed by commercial available kits, respectively. Data are expressed as mean
± SEM (n = 6 per group). #P ＜ 0.05 versus control group; *P ＜ 0.05, **P ＜ 0.01 versus nicotine group.
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Figure 4. Effect of white-fleshed peach extracts (WFPE) on histological changes and nitrotyrosine expression in the liver, kidney, and lung 
tissues of chronic nicotine-injected mice. The liver, kidney, and lung tissues from mice, which were administrated nicotine (5 mg/kg body 
weight [BW]) and/or WFPE (250 mg/kg BW or 500 mg/kg BW) for 5 weeks, were fixed and stained. (A) The morphological features of tissue 
sections were evaluated by Hematoxylin and eosin staining (×200). (B) Nitrotyrosine expressions were evaluated by immunohistochemistry 
(×200).
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epithelial cells. WFPE treatment in nicotine-injected mice 
reduced thickening of the alveolar septa and edema in a 
dose-dependent manner.
We immunohistochemically analyzed the expression of nitro-
tyrosine in the liver, kidney, and lung tissues of the control mice 
and nicotine-injected mice with or without WFPE treatment (Fig. 
4B). Substantially enhanced levels of nitrotyrosine were observed 
in three tissues of nicotine-injected mice. However, WFPE 
treatment dose-dependently inhibited nicotine-induced nitro-
tyrosine formation. 
DISCUSSION
Tobacco smoking was recognized as a major cause of mortality 
and morbidity since environmental tobacco smoke was found to be 
a human lung carcinogen by the US Environmental Protection 
Agency in 1992. Over 4,000 chemicals have been identified in 
tobacco smoke, including 69 known carcinogens and hundreds 
that are hazardous.18 It has been reported that nicotine, a major 
component of tobacco smoke and a highly addictive drug, plays an 
important role in the development of cardiovascular and lung 
diseases.5,19,20 As nicotine enters the human body through tobacco 
smoking, it is efficiently absorbed into the bloodstream through 
the lungs and rapidly delivered to the brain.21 Nicotine is also 
absorbed through the mucosal lining of the mouth and nose, and 
even through the skin. Nicotine is extensively metabolized to a 
number of metabolites; cotinine, the primary metabolite of 
nicotine, is formed after C-oxidation by hepatic cytochrome P450 
(CYP2A6).22 Cotinine is further metabolized by the same enzyme 
system as trans-3'-hydroxycotinine (hydroxycotinine) and other 
minor metabolites including norcotinine.23 PAHs, including the 
widely studied benzo[a]pyrene, are considered the main car-
cinogens of cigarette smoke. PAHs bind to aryl hydrocarbon 
receptor after entering the body, and induce cytochrome P450 
drug-metabolizing enzymes, such as CYP1A1, CYP1A2, CYP1Ba, and 
CYP3A4, which metabolize PAHs into various PAH derivatives, such 
as hydroxylated PAHs and PAH quinones.24 Urinary 
1-hydroxypyrene, a monohydroxylated metabolite of pyrene, has 
been widely used as a biomarker of total PAH uptake in smokers 
and nonsmokers.25
The intake of fruits and vegetables, including flavonoids, is 
closely related to the prevention and reduction in the risk of 
chronic diseases, such as inflammation, various cancers, and 
cardiovascular disorders. P. persica fruits have moderate effects 
on blood circulation, recovery from exhaustion, detoxification, 
reinforcement of immune ability, and cosmetic treatment of the 
skin.26 However, the effect of P. persica fruits on the deto-
xification of smoking has not yet been reported. Thus, we firstly 
investigated whether white-fleshed peaches have effects on the 
excretion of nicotine metabolites and 1-hydroxypyrene in the 
urine of smokers. Intake of white-fleshed peaches increased the 
concentration of nicotine metabolites in the urine of 91.67% of 
smokers. In addition, the concentration of urinary 1-hydro-
xypyrene, the major metabolite of PAH, increased in 83.33% of 
smokers after intake of peach fruit. Thus, intake of 
white-fleshed peaches increased the excretion of nicotine 
metabolites and 1-hydroxypyrene in the smokers. Therefore, 
intake of white-fleshed peaches and related processed foods 
might be an effective method for the detoxification of nicotine 
in smokers and nonsmokers who are exposed to environmental 
tobacco smoke.
Nicotine, a major pharmacologically active component of 
tobacco smoke, triggers an accumulation of free radicals or ROS, 
and consequently causes oxidative stress, cytotoxicity, and tissue 
damage. In our animal study, chronic nicotine exposure inhibited 
a gain of body weight, but this weight loss was blocked in the mice 
that were administered extracts of white-fleshed peach at 250 
mg/kg or 500 mg/kg body weight. These results indicate that 
chronic nicotine exposure eventually induces systemic toxicity, 
and WFPE can suppress nicotine toxicity by being absorbed into 
the bodies of animals.
The liver and kidney are highly susceptible to the oxidative 
stress associated with the toxicity of nicotine. Our results showed 
that chronic nicotine exposure caused hepatic and renal damage 
associated with an accumulation of lipid peroxidation products. 
However, WFPE treatment dose-dependently inhibited nephro-
toxicity and hepatotoxicity by reducing serum levels of BUN, 
creatinine, AST, and ALT. A high-dose of WFPE did not affect the 
functional index of the liver and kidney in normal mice, but did 
reduce nicotine-increased levels of BUN and ALT to levels similar 
to the control group. In addition, a marked increase in the MDA 
level was identified in the liver and kidney homogenates of mice 
chronically exposed to nicotine; oral administration of WFPE 
blocked this increase. Furthermore, WFPE treatment blocked the 
decrease of GSH content and inhibition of antioxidant enzymes 
activities, including SOD, GPx, and CAT, in the liver and kidney 
tissues of nicotine-injected mice. These results show that orally 
administered WFPE attenuates oxidative stress by preventing 
nicotine-induced reductions in GSH content and the activities of 
antioxidant enzymes. 
The lung, the primary site exposed to tobacco smoke, is highly 
susceptible to free radical generation. Our histological data 
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showed nicotine-induced toxicity in the lung tissue, as well as in 
the liver and kidney tissues, but organ damages caused by 
nicotine were decreased by WFPE treatment. In immuno-
histochemistry, nitrotyrosine, a biomarker of oxidative stress, 
was positively expressed in the liver, kidney, and lung tissues of 
nicotine-injected mice, while its expression was dose-depen-
dently suppressed in the WFPE-treated group. Nitrotyrosine is 
formed on tyrosine residues by toxic peroxynitrite derived from 
nitric oxide (NO) and superoxide anion (O2
−), which is elevated 
in conditions of oxidative stress in many diseases, such as infla-
mmation, cytotoxicity, and cancer.27 Therefore, inhibition of 
nicotine-induced nitrotyrosine formation by WFPE treatment 
indicates a decrease of oxidative stress.
In conclusion, WFPE may mitigate nicotine toxicity by 
promoting the excretion of nicotine metabolites. The 
protective effect of WFPE against tissue damages by chronic 
nicotine exposure, may be mediated through the inhibition of 
oxidative stress by enhancing of antioxidant capacities. Thus, 
white-fleshed peach may be a beneficial supplement for 
smokers.
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